JOSEPH E ABBOTT Insider Trading $WST WEST PHARMACEUTICAL SERVICES INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JOSEPH E ABBOTT.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JOSEPH E ABBOTT. JOSEPH E ABBOTT is Corporate Controller in WEST PHARMACEUTICAL SERVICES INC ($WST).
JOSEPH E ABBOTT in WEST PHARMACEUTICAL SERVICES INC
Industry: FABRICATED RUBBER PRODUCTS, NEC [3060]
Position of JOSEPH E ABBOTT: Corporate Controller
Holdings: 18,341 shares
Current Value: $1,571,090
Latest Transaction: Mar 01 2011
$WST Market Capitalization: $6.29B
$WST Previous Close: $85.66
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of JOSEPH E ABBOTT in WEST PHARMACEUTICAL SERVICES INC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 01 2011 | WST | WEST PHARMACEUTICA ... | ABBOTT JOSEPH E | Corporate Controlle ... | Payment of Exercise | F | 41.17 | 38 | 1,564 | 18,341 | 18.4 K to 18.3 K (-0.21 %) |
| Feb 24 2011 | WST | WEST PHARMACEUTICA ... | ABBOTT JOSEPH E | Corporate Controlle ... | Option Exercise | A | 40.85 | 7,420 | 303,107 | 7,420 | |
| Feb 24 2011 | WST | WEST PHARMACEUTICA ... | ABBOTT JOSEPH E | Corporate Controlle ... | Grant | A | 40.85 | 625 | 25,531 | 18,379 | 17.8 K to 18.4 K (+3.52 %) |
| Mar 23 2010 | WST | WEST PHARMACEUTICA ... | ABBOTT JOSEPH E | Corporate Controlle ... | Option Exercise | A | 42.68 | 8,197 | 349,848 | 8,197 | |
| Mar 01 2010 | WST | WEST PHARMACEUTICA ... | ABBOTT JOSEPH E | Corporate Controlle ... | Payment of Exercise | F | 38.65 | 35 | 1,353 | 17,598 | 17.6 K to 17.6 K (-0.20 %) |
| Feb 23 2010 | WST | WEST PHARMACEUTICA ... | ABBOTT JOSEPH E | Corporate Controlle ... | Grant | A | 38.22 | 547 | 20,906 | 17,633 | 17.1 K to 17.6 K (+3.20 %) |
| Aug 26 2009 | WST | WEST PHARMACEUTICA ... | ABBOTT JOSEPH E | Corporate Controlle ... | Option Exercise | M | 14.41 | 6,000 | 86,460 | 0 | |
| Aug 26 2009 | WST | WEST PHARMACEUTICA ... | ABBOTT JOSEPH E | Corporate Controlle ... | Sell | S | 40.80 | 6,000 | 244,794 | 16,932 | 22.9 K to 16.9 K (-26.16 %) |
| Aug 26 2009 | WST | WEST PHARMACEUTICA ... | ABBOTT JOSEPH E | Corporate Controlle ... | Buy | M | 14.41 | 6,000 | 86,460 | 22,932 | 16.9 K to 22.9 K (+35.44 %) |
| Mar 06 2009 | WST | WEST PHARMACEUTICA ... | ABBOTT JOSEPH E | Corporate Controlle ... | Payment of Exercise | F | 29.29 | 37 | 1,084 | 16,766 | 16.8 K to 16.8 K (-0.22 %) |
| Feb 26 2009 | WST | WEST PHARMACEUTICA ... | ABBOTT JOSEPH E | Corporate Controlle ... | Option Exercise | A | 32.09 | 5,500 | 176,495 | 5,500 | |
| Feb 26 2009 | WST | WEST PHARMACEUTICA ... | ABBOTT JOSEPH E | Corporate Controlle ... | Grant | A | 32.09 | 984 | 31,577 | 16,807 | 15.8 K to 16.8 K (+6.22 %) |
| Aug 28 2008 | WST | WEST PHARMACEUTICA ... | ABBOTT JOSEPH E | Corporate Controlle ... | Option Exercise | M | 14.41 | 6,000 | 86,460 | 6,000 | |
| Aug 28 2008 | WST | WEST PHARMACEUTICA ... | ABBOTT JOSEPH E | Corporate Controlle ... | Sell | S | 49.03 | 6,000 | 294,177 | 15,635 | 21.6 K to 15.6 K (-27.73 %) |
| Aug 28 2008 | WST | WEST PHARMACEUTICA ... | ABBOTT JOSEPH E | Corporate Controlle ... | Buy | M | 14.41 | 6,000 | 86,460 | 21,635 | 15.6 K to 21.6 K (+38.38 %) |
| Feb 28 2008 | WST | WEST PHARMACEUTICA ... | ABBOTT JOSEPH E | Corporate Controlle ... | Option Exercise | A | 41.70 | 5,958 | 248,449 | 5,958 | |
| Feb 28 2008 | WST | WEST PHARMACEUTICA ... | ABBOTT JOSEPH E | Corporate Controlle ... | Grant | A | 41.70 | 477 | 19,891 | 15,564 | 15.1 K to 15.6 K (+3.16 %) |
| Feb 28 2008 | WST | WEST PHARMACEUTICA ... | ABBOTT JOSEPH E | Corporate Controlle ... | Grant | A | 41.70 | 1,743 | 72,683 | 15,087 | 13.3 K to 15.1 K (+13.06 %) |
| Feb 14 2008 | WST | WEST PHARMACEUTICA ... | ABBOTT JOSEPH E | Corporate Controlle ... | Payment of Exercise | F | 38.38 | 74 | 2,840 | 13,344 | 13.4 K to 13.3 K (-0.55 %) |
| Mar 02 2007 | WST | WEST PHARMACEUTICA ... | ABBOTT JOSEPH E | Corporate Controlle ... | Payment of Exercise | F | 45.35 | 36 | 1,633 | 14,080 | 14.1 K to 14.1 K (-0.26 %) |
| Mar 01 2007 | WST | WEST PHARMACEUTICA ... | ABBOTT JOSEPH E | Corporate Controlle ... | Option Exercise | A | 44.97 | 5,707 | 256,644 | 5,707 | |
| Mar 01 2007 | WST | WEST PHARMACEUTICA ... | ABBOTT JOSEPH E | Corporate Controlle ... | Grant | A | 44.77 | 2,240 | 100,285 | 14,116 | 11.9 K to 14.1 K (+18.86 %) |
| Mar 01 2007 | WST | WEST PHARMACEUTICA ... | ABBOTT JOSEPH E | Corporate Controlle ... | Grant | A | 44.77 | 544 | 24,355 | 11,876 | 11.3 K to 11.9 K (+4.80 %) |
| Nov 08 2006 | WST | WEST PHARMACEUTICA ... | ABBOTT JOSEPH E | Corporate Controlle ... | Option Exercise | M | 11.30 | 5,000 | 56,475 | 0 | |
| Nov 08 2006 | WST | WEST PHARMACEUTICA ... | ABBOTT JOSEPH E | Corporate Controlle ... | Sell | S | 47.00 | 5,000 | 235,000 | 11,262 | 16.3 K to 11.3 K (-30.75 %) |
| Nov 08 2006 | WST | WEST PHARMACEUTICA ... | ABBOTT JOSEPH E | Corporate Controlle ... | Buy | M | 11.30 | 5,000 | 56,475 | 16,262 | 11.3 K to 16.3 K (+44.40 %) |
| Aug 30 2006 | WST | WEST PHARMACEUTICA ... | ABBOTT JOSEPH E | Corporate Controlle ... | Option Exercise | M | 11.30 | 5,000 | 56,475 | 5,000 | |
| Aug 30 2006 | WST | WEST PHARMACEUTICA ... | ABBOTT JOSEPH E | Corporate Controlle ... | Sell | S | 38.51 | 5,000 | 192,548 | 15,760 | 20.8 K to 15.8 K (-24.08 %) |
| Aug 30 2006 | WST | WEST PHARMACEUTICA ... | ABBOTT JOSEPH E | Corporate Controlle ... | Buy | M | 11.30 | 5,000 | 56,475 | 20,760 | 15.8 K to 20.8 K (+31.73 %) |
| Aug 16 2006 | WST | WEST PHARMACEUTICA ... | ABBOTT JOSEPH E | Corporate Controlle ... | Option Exercise | M | 11.30 | 6,000 | 67,770 | 10,000 | |
| Aug 16 2006 | WST | WEST PHARMACEUTICA ... | ABBOTT JOSEPH E | Corporate Controlle ... | Sell | S | 37.48 | 6,000 | 224,880 | 15,760 | 21.8 K to 15.8 K (-27.57 %) |
| Aug 16 2006 | WST | WEST PHARMACEUTICA ... | ABBOTT JOSEPH E | Corporate Controlle ... | Buy | M | 11.30 | 6,000 | 67,770 | 21,760 | 15.8 K to 21.8 K (+38.07 %) |
| May 03 2006 | WST | WEST PHARMACEUTICA ... | ABBOTT JOSEPH E | Corporate Controlle ... | Sell | S | 36.63 | 3,000 | 109,880 | 15,760 | 18.8 K to 15.8 K (-15.99 %) |
| May 03 2006 | WST | WEST PHARMACEUTICA ... | ABBOTT JOSEPH E | Corporate Controlle ... | Buy | M | 13.38 | 3,000 | 40,125 | 18,760 | 15.8 K to 18.8 K (+19.04 %) |
| Mar 01 2006 | WST | WEST PHARMACEUTICA ... | ABBOTT JOSEPH E | Corporate Controlle ... | Option Exercise | M | 13.38 | 3,000 | 40,125 | 3,000 | |
| Mar 01 2006 | WST | WEST PHARMACEUTICA ... | ABBOTT JOSEPH E | Corporate Controlle ... | Sell | S | 32.61 | 3,000 | 97,841 | 17,346 | 20.3 K to 17.3 K (-14.74 %) |
| Mar 01 2006 | WST | WEST PHARMACEUTICA ... | ABBOTT JOSEPH E | Corporate Controlle ... | Buy | M | 13.38 | 3,000 | 40,125 | 20,346 | 17.3 K to 20.3 K (+17.30 %) |
| Feb 28 2006 | WST | WEST PHARMACEUTICA ... | ABBOTT JOSEPH E | Corporate Controlle ... | Option Exercise | A | 32.59 | 4,641 | 151,227 | 4,641 | |
| Feb 28 2006 | WST | WEST PHARMACEUTICA ... | ABBOTT JOSEPH E | Corporate Controlle ... | Grant | A | 0.00 | 500 | 0 | 17,346 | 16.8 K to 17.3 K (+2.97 %) |
| Feb 28 2006 | WST | WEST PHARMACEUTICA ... | ABBOTT JOSEPH E | Corporate Controlle ... | Grant | A | 32.59 | 468 | 15,250 | 16,846 | 16.4 K to 16.8 K (+2.86 %) |
| Feb 28 2006 | WST | WEST PHARMACEUTICA ... | ABBOTT JOSEPH E | Corporate Controlle ... | Grant | A | 0.00 | 1,586 | 0 | 16,378 | 14.8 K to 16.4 K (+10.72 %) |
| Mar 09 2005 | WST | WEST PHARMACEUTICA ... | ABBOTT JOSEPH E | Corporate Controlle ... | Option Exercise | A | 25.53 | 7,000 | 178,710 | 7,000 | |
| Mar 09 2005 | WST | WEST PHARMACEUTICA ... | ABBOTT JOSEPH E | Corporate Controlle ... | Grant | A | 25.57 | 599 | 15,316 | 15,322 | 14.7 K to 15.3 K (+4.07 %) |
| Mar 09 2005 | WST | WEST PHARMACEUTICA ... | ABBOTT JOSEPH E | Corporate Controlle ... | Grant | A | 0.00 | 1,635 | 0 | 14,724 | 13.1 K to 14.7 K (+12.49 %) |
| Jan 20 2005 | WST | WEST PHARMACEUTICA ... | ABBOTT JOSEPH E | Corporate Controlle ... | Option Exercise | M | 13.38 | 6,000 | 80,250 | 6,000 | |
| Jan 20 2005 | WST | WEST PHARMACEUTICA ... | ABBOTT JOSEPH E | Corporate Controlle ... | Payment of Exercise | F | 25.63 | 1,056 | 27,060 | 13,063 | 14.1 K to 13.1 K (-7.48 %) |
| Jan 20 2005 | WST | WEST PHARMACEUTICA ... | ABBOTT JOSEPH E | Corporate Controlle ... | Payment of Exercise | F | 25.63 | 3,132 | 80,258 | 14,119 | 17.3 K to 14.1 K (-18.16 %) |
| Jan 20 2005 | WST | WEST PHARMACEUTICA ... | ABBOTT JOSEPH E | Corporate Controlle ... | Buy | M | 13.38 | 6,000 | 80,250 | 17,251 | 11.3 K to 17.3 K (+53.33 %) |
| Nov 17 2004 | WST | WEST PHARMACEUTICA ... | ABBOTT JOSEPH E | Corporate Controlle ... | Option Exercise | M | 13.02 | 3,000 | 39,047 | 0 | |
| Nov 17 2004 | WST | WEST PHARMACEUTICA ... | ABBOTT JOSEPH E | Corporate Controlle ... | Payment of Exercise | F | 23.29 | 405 | 9,432 | 11,251 | 11.7 K to 11.3 K (-3.47 %) |
| Nov 17 2004 | WST | WEST PHARMACEUTICA ... | ABBOTT JOSEPH E | Corporate Controlle ... | Payment of Exercise | F | 23.29 | 1,677 | 39,057 | 11,656 | 13.3 K to 11.7 K (-12.58 %) |
| Nov 17 2004 | WST | WEST PHARMACEUTICA ... | ABBOTT JOSEPH E | Corporate Controlle ... | Buy | M | 13.02 | 3,000 | 39,047 | 13,333 | 10.3 K to 13.3 K (+29.03 %) |
| Jul 01 2004 | WST | WEST PHARMACEUTICA ... | ABBOTT JOSEPH E | Corporate Controlle ... | Grant | A | 40.88 | 1,903 | 77,795 | 5,157 | 3.3 K to 5.2 K (+58.48 %) |
| Jul 01 2004 | WST | WEST PHARMACEUTICA ... | ABBOTT JOSEPH E | Corporate Controlle ... | Grant | A | 40.88 | 1,903 | 77,795 | 5,157 | 3.3 K to 5.2 K (+58.48 %) |
| May 07 2004 | WST | WEST PHARMACEUTICA ... | ABBOTT JOSEPH E | Corporate Controlle ... | Option Exercise | A | 38.73 | 4,100 | 158,793 | 4,100 | |
| May 07 2004 | WST | WEST PHARMACEUTICA ... | ABBOTT JOSEPH E | Corporate Controlle ... | Grant | A | 0.00 | 1,097 | 0 | 3,254 | 2.2 K to 3.3 K (+50.86 %) |
| May 07 2004 | WST | WEST PHARMACEUTICA ... | ABBOTT JOSEPH E | Corporate Controlle ... | Grant | A | 36.50 | 498 | 18,177 | 2,157 | 1.7 K to 2.2 K (+30.02 %) |
| May 07 2004 | WST | WEST PHARMACEUTICA ... | ABBOTT JOSEPH E | Corporate Controlle ... | Option Exercise | A | 38.73 | 4,100 | 158,793 | 4,100 | |
| May 07 2004 | WST | WEST PHARMACEUTICA ... | ABBOTT JOSEPH E | Corporate Controlle ... | Grant | A | 0.00 | 1,097 | 0 | 3,254 | 2.2 K to 3.3 K (+50.86 %) |
| May 07 2004 | WST | WEST PHARMACEUTICA ... | ABBOTT JOSEPH E | Corporate Controlle ... | Grant | A | 36.50 | 498 | 18,177 | 2,157 | 1.7 K to 2.2 K (+30.02 %) |
| Apr 01 2004 | WST | WEST PHARMACEUTICA ... | ABBOTT JOSEPH E | Corporate Controlle ... | Option Exercise | M | 32.84 | 1,137 | 37,343 | 363 | |
| Apr 01 2004 | WST | WEST PHARMACEUTICA ... | ABBOTT JOSEPH E | Corporate Controlle ... | Payment of Exercise | F | 37.20 | 1,003 | 37,312 | 1,659 | 2.7 K to 1.7 K (-37.68 %) |
| Apr 01 2004 | WST | WEST PHARMACEUTICA ... | ABBOTT JOSEPH E | Corporate Controlle ... | Payment of Exercise | F | 37.20 | 47 | 1,748 | 2,662 | 2.7 K to 2.7 K (-1.73 %) |
| Apr 01 2004 | WST | WEST PHARMACEUTICA ... | ABBOTT JOSEPH E | Corporate Controlle ... | Buy | M | 32.84 | 1,137 | 37,343 | 2,709 | 1.6 K to 2.7 K (+72.33 %) |
Page: 1